Brigitre Tempelmaier

Title: Brigitre Tempelmaier: Innovator in Antigen Production

Introduction

Brigitre Tempelmaier is an accomplished inventor based in Vienna, Austria. He holds a significant patent that focuses on the identification, isolation, and production of antigens related to specific pathogens. His work has potential implications in the fields of vaccinations and immunology.

Latest Patents

Brigitre's notable patent describes a method that details the process of identifying and producing hyperimmune serum-reactive antigens from various sources, including specific pathogens, tumors, allergens, or tissues prone to autoimmunity. The method includes a series of precise steps:

- Providing an antibody preparation derived from a plasma pool.

- Developing expression libraries of the specific target.

- Screening these libraries using the antibody preparation.

- Identifying antigens that bind during the screening process.

- Further screening with individual sera to pinpoint hyperimmune serum-reactive antigens, which can be isolated and produced via chemical or recombinant methods.

This innovative approach could significantly improve vaccine efficacy for both humans and animals.

Career Highlights

Brigitre Tempelmaier works at Intercell AG, a biotechnology company that specializes in vaccine development and pathogen discovery. His inventive contributions to antigen production underscore his commitment to advancing medical science and addressing health challenges through innovative solutions.

Collaborations

Throughout his career, Brigitre has collaborated with talented professionals in his field. Notable colleagues include Andreas Meinke and Eszter Nagy, who have worked alongside him to further research and applications of antigen identification methods. Their collective expertise enhances the scope and impact of their research efforts.

Conclusion

Brigitre Tempelmaier is a key figure in the innovative landscape of antigen production and vaccine development. His dedication to improving medical science through his patented methods marks him as a forward-thinking inventor in the field. With ongoing collaborations and a focus on groundbreaking research, Brigitre continues to drive advancements that can benefit animal and human health alike.